Kras-mutation influences outcomes for palliative primary tumor resection in advanced colorectal cancer-a Turkish Oncology Group study

Korkmaz, Levent; COŞKUN, HASAN; DANE, FAYSAL; KARABULUT, BÜLENT; Karaagac, Mustafa; ÇABUK, DEVRİM; Karabulut, SENEM; Aykan, Nuri; Doruk, Hatice; Avci, Nilufer; Turhal, Nazim; Artac, Mehmet

doi:10.1016/j.suronc.2018.05.032

Kras-mutation influences outcomes for palliative primary tumor resection in advanced colorectal cancer-a Turkish Oncology Group study

Korkmaz L., COŞKUN H. Ş., DANE F., KARABULUT B., Karaagac M., ÇABUK D., ...Daha Fazla

SURGICAL ONCOLOGY-OXFORD, cilt.27, sa.3, ss.485-489, 2018 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 27 Sayı: 3
Basım Tarihi: 2018
Doi Numarası: 10.1016/j.suronc.2018.05.032
Dergi Adı: SURGICAL ONCOLOGY-OXFORD
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.485-489
İstanbul Üniversitesi Adresli: Evet

Özet

Purpose: We aimed to investigate the prognostic effect of primary tumor resection (PTR) prior to bevacizumab-based treatments in unresectable metastatic colorectal cancer (mCRC).